Therapeutic efficacy of NSC606985, a novel camptothecin analog, in a mouse model of acute promyelocytic leukemia
- PMID: 17428537
- DOI: 10.1016/j.leukres.2007.03.011
Therapeutic efficacy of NSC606985, a novel camptothecin analog, in a mouse model of acute promyelocytic leukemia
Abstract
Nanomolar concentrations of NSC606985, a novel camptothecin (CPT) analog, effectively induces apoptosis in vitro in acute myeloid leukemic (AML) cells. Here we investigated the potential therapeutic effects of NSC606985 on the mice model with acute promyelocytic leukaemia (APL), a unique subtype of AML. The results showed that NSC606985 at single dose rapidly eliminated the infiltration with apoptosis induction of leukemic cells in peripheral blood and tissues. Treatment of NSC606985 with two regimens, continuous monotherapy and intermittent long-term therapy, significantly prolonged the survival of leukemic mice with tumor regression. These results propose that NSC606985 warrants further preclinical and clinical investigations for AML treatment.
Similar articles
-
Nanomolar concentration of NSC606985, a camptothecin analog, induces leukemic-cell apoptosis through protein kinase Cdelta-dependent mechanisms.Blood. 2005 May 1;105(9):3714-21. doi: 10.1182/blood-2004-10-4011. Epub 2005 Jan 25. Blood. 2005. PMID: 15671440
-
Phosphorylation of beta-actin by protein kinase C-delta in camptothecin analog-induced leukemic cell apoptosis.Acta Pharmacol Sin. 2008 Jan;29(1):135-42. doi: 10.1111/j.1745-7254.2008.00753.x. Acta Pharmacol Sin. 2008. PMID: 18158875
-
Subcellular proteome analysis of camptothecin analogue NSC606985-treated acute myeloid leukemic cells.J Proteome Res. 2007 Sep;6(9):3808-18. doi: 10.1021/pr0700100. Epub 2007 Jul 27. J Proteome Res. 2007. PMID: 17655343
-
Acute promyelocytic leukemia: from treatment to genetics and back.Oncogene. 1999 Sep 20;18(38):5261-7. doi: 10.1038/sj.onc.1202996. Oncogene. 1999. PMID: 10498878 Review. No abstract available.
-
The expanding role of arsenic in acute promyelocytic leukemia.Semin Hematol. 2008 Jul;45(3 Suppl 2):S25-9. doi: 10.1053/j.seminhematol.2008.07.008. Semin Hematol. 2008. PMID: 18760708 Review.
Cited by
-
Camptothecin-20(s)-O-[N-(3'α,12'α-dihydroxy-24'-carbonyl-5'β-cholan)]-lysine, a novel camptothecin analogue, induces apoptosis towards hepatocellular carcinoma SMMC-7721 cells.Molecules. 2011 Sep 13;16(9):7803-14. doi: 10.3390/molecules16097803. Molecules. 2011. PMID: 22143544 Free PMC article.
-
Anti-proliferative and apoptosis-inducing effects of camptothecin-20(s)-O-(2-pyrazolyl-1)acetic ester in human breast tumor MCF-7 cells.Molecules. 2014 Apr 17;19(4):4941-55. doi: 10.3390/molecules19044941. Molecules. 2014. PMID: 24747650 Free PMC article.
-
NSC606985, a novel camptothecin analog, induces apoptosis and growth arrest in prostate tumor cells.Cancer Chemother Pharmacol. 2009 Jan;63(2):303-12. doi: 10.1007/s00280-008-0740-8. Epub 2008 Mar 29. Cancer Chemother Pharmacol. 2009. PMID: 18373093 Free PMC article.
-
Protein kinase Cdelta stimulates proteasome-dependent degradation of C/EBPalpha during apoptosis induction of leukemic cells.PLoS One. 2009 Aug 7;4(8):e6552. doi: 10.1371/journal.pone.0006552. PLoS One. 2009. PMID: 19662097 Free PMC article.
-
Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?Am J Cancer Res. 2017 Dec 1;7(12):2350-2394. eCollection 2017. Am J Cancer Res. 2017. PMID: 29312794 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
